Arrowstreet Capital’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-123,019
| Closed | -$30.2M | – | 1524 |
|
|
2022
Q3 | $30.2M | Buy |
123,019
+18,027
| +17% | +$4.43M | 0.04% | 304 |
|
|
2022
Q2 | $26M | Buy |
104,992
+76,712
| +271% | +$19M | 0.04% | 331 |
|
|
2022
Q1 | $9.37M | Sell |
28,280
-38,363
| -58% | -$12.7M | 0.01% | 525 |
|
|
2021
Q4 | $23.9M | Sell |
66,643
-13,231
| -17% | -$4.75M | 0.03% | 438 |
|
|
2021
Q3 | $26M | Buy |
79,874
+33,581
| +73% | +$10.9M | 0.03% | 456 |
|
|
2021
Q2 | $14.4M | Buy |
+46,293
| New | +$14.4M | 0.02% | 717 |
|
|
2019
Q2 | – | Sell |
-15,118
| Closed | -$4.32M | – | 1806 |
|
|
2019
Q1 | $4.32M | Sell |
15,118
-26,300
| -63% | -$7.51M | 0.01% | 844 |
|
|
2018
Q4 | $13.5M | Buy |
41,418
+19,500
| +89% | +$6.34M | 0.04% | 372 |
|
|
2018
Q3 | $9.86M | Buy |
+21,918
| New | +$9.86M | 0.02% | 415 |
|
|
2018
Q2 | – | Sell |
-41,100
| Closed | -$12M | – | 1358 |
|
|
2018
Q1 | $12M | Buy |
41,100
+23,544
| +134% | +$6.85M | 0.03% | 408 |
|
|
2017
Q4 | $3.29M | Buy |
+17,556
| New | +$3.29M | 0.01% | 701 |
|
|
2017
Q3 | – | Sell |
-26,500
| Closed | -$3.8M | – | 1287 |
|
|
2017
Q2 | $3.8M | Sell |
26,500
-122,514
| -82% | -$17.6M | 0.01% | 524 |
|
|
2017
Q1 | $18.7M | Buy |
+149,014
| New | +$18.7M | 0.07% | 280 |
|
|
2016
Q4 | – | Sell |
-548,951
| Closed | -$70.6M | – | 2661 |
|
|
2016
Q3 | $70.6M | Buy |
548,951
+299,201
| +120% | +$38.5M | 0.23% | 103 |
|
|
2016
Q2 | $27.3M | Buy |
+249,750
| New | +$27.3M | 0.09% | 223 |
|
|
2016
Q1 | – | Sell |
-13,710
| Closed | -$1.24M | – | 1591 |
|
|
2015
Q4 | $1.24M | Sell |
13,710
-81,690
| -86% | -$7.38M | 0.01% | 929 |
|
|
2015
Q3 | $8.85M | Sell |
95,400
-39,600
| -29% | -$3.67M | 0.04% | 375 |
|
|
2015
Q2 | $8.87M | Buy |
+135,000
| New | +$8.87M | 0.05% | 294 |
|
|
2015
Q1 | – | Sell |
-17,074
| Closed | -$650K | – | 1276 |
|
|
2014
Q4 | $650K | Buy |
+17,074
| New | +$650K | ﹤0.01% | 990 |
|